OR WAIT null SECS
Project to focus on improving access to EstroGel.
LifeMD, Inc. revealed in a company press release that is has agreed to terms on a partnership with Ascend Therapeutics, a subsidiary of Besins Healthcare and a specialty pharmaceutical company concentrating on women's health. As per the deal, the collaboration aims to provide integrated telehealth services to improve access to EstroGel 0.06% (estradiol gel), with LifeMD’s telehealth services now available on Ascend’s website.
“This agreement with Ascend Therapeutics, a global market leader improving women’s lives with a focus on innovative hormone therapies, is an example of an increasing number of pharmaceutical partnerships applying LifeMD technology and aptitude in consumer healthcare engagement,” said Justin Schreiber, chairman, CEO, LifeMD. “By providing patient access to a high-quality physician at the moment they are searching for treatment, we are removing barriers to care – like lengthy appointment wait times and risk of inconsistent care by less experienced practitioners – while also improving health outcomes by providing on-demand and ongoing access to primary care providers.”
Reference: LifeMD and ASCEND Therapeutics Launch Integrated Direct-to-Consumer Telehealth Model for Hormone Therapy. LifeMD. September 21, 2023. Accessed September 22, 2023. https://ir.lifemd.com/press-release-details.php#/?newsId=2747072